Clinical Trials Logo
  1. Home
  2. Cholecystitis
  3. NCT05770128
  4. Details
NCT05770128 Clinical Trial

Subserosal Laparoscopic Cholecystectomy

Cholecystitis Clinical Trial

Official title:
Subserosal Laparoscopic Cholecystectomy for Safe Gall Bladder Surgery

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT05770128
Other study ID # cholecystectomy by laparoscpe
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date May 1, 2023
Est. completion date December 1, 2023

Study information
Verified date March 2023
Source Assiut University
Contact Ahmed M. Hussein, resident
Phone +201010729020
Email ahmed.s7s1929@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim is to study the safety and efficacy of subserosal laparoscopic cholecystectomy .

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 65
Est. completion date December 1, 2023
Est. primary completion date November 1, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Adult with age of or above 18 years. - Diagnosis of chronic cholecystitis , symptomatic cholelithiasis Exclusion Criteria: - Previous operation or adhesion - severe Acute Calculus pancreatitis - gall bladder cancer - Severe co-morbid conditions (uncontrolled diabetes, Hypertension, severe direct hyper bilirubinemia) - Recurrent cases

Study Design

Related Conditions & MeSH terms

Intervention

Procedure:
• laparoscope
subserosal manipulation of gallbladder with laparoscope .

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Assiut University

Outcome
Type Measure Description Time frame Safety issue
Primary Detection of safety of subserosal laparoscopic cholecystectomy in comparison to conventional technique. incidence of bleeding after subserosal laparoscopic cholecystectomy in comparison to conventional technique. 6 months
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03636841 - Reduction of Operating Time by a Smoke Electroprecipitation Device for Acute Cholecystitis N/A
Completed NCT02379780 - Ultrasound Guided Subcostal Transversus Abdominis Plane Versus Paravertebral Block in the Laparoscopic Cholecystectomy N/A
Completed NCT01937104 - ONSD According to the Position During Laparoscopy N/A
Completed NCT02461147 - Prospective Validation of "Cholecystectomy First" Strategy for Gallstone Migration
Completed NCT02264444 - Establishing Visualization Grading Scale on LESS Cholecystectomy N/A
Completed NCT01476995 - Prognostic Indicators as Provided by the EPIC ClearView N/A
Completed NCT00746850 - Harmonic in Laparoscopic Cholecystectomy for Acute Cholecystitis N/A
Completed NCT00940264 - Laparoscopic Transvaginal Hybrid Cholecystectomy: a Prospective Data Collection. N/A
Completed NCT00370344 - Small-incision Open Cholecystectomy or Laparoscopic Cholecystectomy for Gallbladder Disease Phase 2/Phase 3
Completed NCT00195351 - Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection Phase 4
Completed NCT02858986 - 3D Versus 4K Laparoscopic Cholecystectomy N/A
Completed NCT04602156 - US-guided Trocar Versus Seldiger Technique for Percutaneous Cholecystostomy N/A
Completed NCT04942665 - Low Dose ICG for Biliary Tract and Tumor Imaging Phase 2
Completed NCT02547064 - Effect of Modified Stylet Angulation on the Intubation With GlideScope® N/A
Completed NCT00230971 - Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI) Phase 4
Completed NCT04122261 - A Clinical Study of Chinese Domestic Surgical Robot N/A
Completed NCT04716166 - Incentive Spirometry and Upper Abdominal Laparoscopic Surgery N/A
Completed NCT01476319 - Improving Informed Consent Process for Percutaneous Cholecystostomy in the Emergency Department N/A
Withdrawn NCT02225418 - Transmuscular Quadratus Lumborum Block for Laparoscopic Cholecystectomy N/A
Suspended NCT04306939 - Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study